ArticleACS organic & inorganic Au2025
Green Synthesis of Biocompatible Gold Nanoparticles Using
Article in ACS organic & inorganic Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Biocompatibility of Human Fibroblast Cells Exposed to Gold Nanoparticles Synthesized by Environmentally Friendly Route.ACS omega · 2026Article
- Green-synthesized N-acetylcarnosine-loaded gold nanoparticles as a novel ocular nanocarrier for antioxidant therapy and cataract prevention.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally, breast cancer is the second leading cause of cancer-related mortality among women. Early detection, accurate diagnosis, and timely treatment are critical for improving survival rates. Therefore, developing a rapid and highly sensitive diagnostic method for early-stage breast cancer detection is essential. Human epidermal growth factor receptor 2 (HER2) is a well-characterized indicator of aggressiveness and poor prognosis in various cancers, including breast cancer. HER2-positive breast cancer represents about 15-20% of all cases, highlighting the significance of HER2 as both a prognostic and predictive biomarker. Gold nanoparticles (AuNPs) have emerged as promising tools in cancer diagnostics due to their unique optical and physicochemical properties. Among these, green-synthesized AuNPs are particularly attractive for biomedical applications due to their eco-friendliness and biocompatibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.